{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Highlights From 2025 TCT Conference","description":" In this week\u2019s View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco. The SELUTION DeNovo trial found that use of the sirolimus-eluting balloons with bailout stenting only if necessary was noninferior to routine drug-eluting stent implantation in patients with de novo coronary artery disease. In the ANDES trial, results showed that the use of direct oral anticoagulants after left atrial appendage closure in patients with non-valvular atrial fibrillation was not superior to dual antiplatelet therapy in preventing device-related thrombosis. Finally, Dr. Eagle discusses the PROCTOR study in which percutaneous coronary intervention (PCI) on saphenous vein grafts versus native vessel PCI in post-coronary artery bypass grafting in patients presenting with graft failure.    Subscribe to Eagle\u2019s Eye View     ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"